GI
ITCI

GAMCO Investors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

GAMCO Investors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,100
Closed -$5.03M – 1076
2025
Q1 		$5.03M Buy
+38,100
New +$4.75M 0.06% 325

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAMCO Investors's ITCI Position: Q2 2025 in Review

GAMCO Investors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 38,100 shares — an estimated $5.03M sold.

GAMCO Investors first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $5.03M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • GAMCO Investors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • GAMCO Investors sold 38,100 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $5.03M.
  • GAMCO Investors first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • GAMCO Investors's Intra-Cellular Therapies Inc. position peaked at $5.03M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on GAMCO Investors's 13F filing for Q2 2025, filed 13 Aug 2025.